Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes

2004 ◽  
Vol 106 (1) ◽  
pp. 93-98 ◽  
Author(s):  
V. TOESCU ◽  
S. L. NUTTALL ◽  
U. MARTIN ◽  
P. NIGHTINGALE ◽  
M. J. KENDALL ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Pregnant Women ◽  
Total Cholesterol ◽  
Type Ii Diabetes ◽  
Plasma Lipids ◽  
Lipid Hydroperoxides ◽  
Type I ◽  
Type Ii ◽  
Markers Of Oxidative Stress ◽  
Normal Women

The purpose of the present study was to determine changes in plasma lipids and markers of oxidative stress longitudinally in pregnancy complicated by diabetes compared with non-diabetic pregnancy. This was carried out by following a group of normal pregnant women (n=17) and groups of pregnant women with Type I diabetes (n=19), Type II diabetes (n=12) and gestational diabetes mellitus (n=12) throughout pregnancy, with sampling carried out at the end of each trimester. Serum total cholesterol and triacylglycerols (triglycerides) were determined using standard colorimetric techniques and low-density lipoprotein (LDL) subfraction profile by disc PAGE. Total antioxidant capacity (TAC) was determined by enhanced chemiluminescence and lipid hydroperoxides by the ferrous oxidation of Xylenol Orange method. Total cholesterol and triacylglycerols increased significantly throughout pregnancy in all groups, but there were no significant differences between normal and diabetic women with respect to either. The LDL score was significantly higher (P<0.001) in diabetic women compared with normal women at each point throughout pregnancy, although there were no significant differences between the diabetic groups. There was evidence of greater oxidative stress in diabetic compared with normal women throughout. Corrected TAC was significantly lower (P<0.001) in all diabetic women throughout pregnancy. In addition, lipid hydroperoxides were higher in all diabetic compared with normal women, particularly so in those with Type II diabetes (P<0.05). These changes may have important implications for diabetic women during pregnancy, as an elevated risk of pre-eclampsia is thought to reflect an oxidative stress-related mechanism. In addition, these changes may have important implications for the development of atherosclerosis and the long-term cardiovascular health of women with diabetes.

PONI and its association with oxidative stress in type I and type II diabetes mellitus

2011 ◽  
Vol 5 (3) ◽  
pp. 126-129 ◽  
Author(s):  
Sandhya Pillai Nair ◽  
N.C. Shah ◽  
Anand Taggarsi ◽  
Uma Nayak
Keyword(s):  
Oxidative Stress ◽  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type I ◽  
Type Ii

Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus

1998 ◽  
Vol 95 (3) ◽  
pp. 331-337 ◽  
Author(s):  
K. KRAPFENBAUER ◽  
R. BIRNBACHER ◽  
H. VIERHAPPER ◽  
K. HERKNER ◽  
D. KAMPEL ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Diabetes Mellitus ◽  
Hydroxyl Radical ◽  
Protein Oxidation ◽  
Type Ii Diabetes ◽  
Dna Oxidation ◽  
Type I ◽  
Type Ii ◽  
Patients With Diabetes ◽  
Radical Attack

1.The role of oxidative stress in the pathogenesis of the diabetic state is being investigated extensively. Although oxidative stress has been reported in terms of glycoxidation, protein oxidation and DNA oxidation in diabetes mellitus, oxidation parameters have not been determined in parallel on the same study population. 2.We studied 24 patients with diabetes mellitus (14 patients with Type I diabetes with a mean age of 62.3±6.3 years and 10 patients with Type II diabetes aged 67.3±5.9 years) and compared them with age-matched non-diabetic controls. Urinary o-tyrosine, 8-hydroxy-2′-deoxyguanosine and pentosidine measurements by HPLC were made on two occasions (t1 and t2). 3.A clear statistical difference was found between diabetic patients and controls at t1 or t2 for 8-hydroxy-2′-deoxyguanosine and pentosidine, but not for o-tyrosine. No significant correlations were found between clinical and other laboratory parameters except high-density lipoprotein and uric acid. We revealed significantly increased glycoxidation and DNA oxidation in patients with Type I and Type II diabetes, but protein oxidation was not different from controls. 4.The finding of increased glycoxidation reflects increased oxidation of the carbohydrate moiety, whereas the increased levels of oxidized DNA may also be interpreted as due to increased DNA repair. The increased 8-hydroxy-2′-deoxyguanosine does not indicate the generation of an individual active oxygen species, but DNA could have been oxidized simply by alkenals from lipid peroxidation, as e.g. malondialdehyde. As no difference in protein oxidation (i.e. o-tyrosine) between diabetics and controls could be revealed, the oxidation of DNA by hydroxyl radical attack is unlikely, as o-tyrosine was proposed as a marker for hydroxyl radical attack. Therefore, the message is that increased glycoxidation can be confirmed, protein oxidation does not appear to take place and increased DNA oxidation is still not proven, as increased 8-hydroxy-2′-deoxyguanosine may simply reflect repair.

scholarly journals P006: Characterizing patients with newly-diagnosed diabetes mellitus in the emergency department: A one-year health records review

CJEM ◽  
2017 ◽  
Vol 19 (S1) ◽  
pp. S79
Author(s):  
H. Ali Khan ◽  
K. Gushulak ◽  
M. Columbus ◽  
I.G. Stiell ◽  
J.W. Yan
Keyword(s):  
Diabetic Ketoacidosis ◽  
Type Ii Diabetes ◽  
Type I ◽  
Type Ii ◽  
Newly Diagnosed ◽  
Health Records ◽  
The Mean ◽  
One Year ◽  
Diagnosed Diabetes ◽  
Newly Diagnosed Diabetes

Introduction: Diabetes mellitus is an increasingly prevalent chronic condition that is usually managed in an outpatient setting. However, the emergency department (ED) plays a crucial role in the management of diabetic patients, particularly for those who are presenting with newly diagnosed diabetes. Little research has been done to characterize the population of patients presenting to the ED with hyperglycemia with no previous diagnosis of diabetes. The objective of this study was to describe the epidemiology, treatment, and outcomes of patients who were newly diagnosed with diabetes in the ED and to compare those with newly diagnosed type I versus type II diabetes. Methods: A one-year health records review of newly diagnosed diabetes patients ≥18 years presenting to one of four tertiary care EDs was conducted. All patients with a discharge diagnosis of hyperglycemia, diabetic ketoacidosis or hyperosmolar hyperglycemic syndrome were screened, but only those who did not have a previous history of diabetes were included. Trained research personnel collected data on patient characteristics, management, disposition, and outcome. Descriptive statistics were used to summarize the data where appropriate. Results: Of 645 patients presenting with hyperglycemia in the study period, 112 (17.4%) were newly diagnosed diabetes patients. Of these patients, 30 (26.8%) were later diagnosed with type I diabetes and 82 (73.2%) were diagnosed with type II diabetes. For the newly diagnosed type I patients the mean (SD) age was 27.6 (9.9) and the mean (SD) age for type II patients was 52.4 (14.1). Of all the new onset patients, 26.8% were diagnosed with diabetic ketoacidosis. The percentage of patients diagnosed with diabetic ketoacidosis was higher in type I than type II (63.3% vs 13.4%; P&lt;0.01). A total of 49 (43.8%) patients were admitted to the hospital, and more patients with type I were admitted compared to those with type II (66.7% vs 35.4 %; P&lt;0.01). Conclusion: Limited research has been done to describe patients newly diagnosed with diabetes in the ED. Patients with type I were found to be more likely to present to the ED with serious symptoms requiring admission to hospital. Our findings demonstrate that the ED may have a strong potential role for improving diabetic care, by providing future opportunities for education and follow-up in the ED to reduce complications, particularly in type I.

scholarly journals Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women

2018 ◽  
Vol 15 (12) ◽  
pp. 2719 ◽  
Author(s):  
Magdalena Chełchowska ◽  
Jadwiga Ambroszkiewicz ◽  
Joanna Gajewska ◽  
Joanna Mazur ◽  
Leszek Lewandowski ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Nitric Oxide ◽  
Pregnant Women ◽  
Smoking Status ◽  
Multivariate Regression Analysis ◽  
Smoking During Pregnancy ◽  
Women Subjects ◽  
Total Antioxidant ◽  
Markers Of Oxidative Stress ◽  
Oxide Synthase

Smoking tobacco can impair proper vascular endothelial functioning. This is exhibited through reduced nitric oxide synthesis as well as activity due to accompanying oxidative stress. We examined the relationship between nitric oxide and markers of oxidative stress/antioxidant defense in serum of smoking and non-smoking pregnant women. Subjects included 99 healthy pregnant women, who were tested for nitric oxide (NO), endothelial (eNOS) and inducible (iNOS) nitric oxide synthase, total oxidant capacity (TOC), and total antioxidant capacity (TAC). NO, eNOS, and TAC serum concentrations were significantly lower (p < 0.005), but iNOS (p < 0.05) and TOC (p < 0.001) were higher in smokers than in non-smokers. Multivariate regression analysis showed associations between NO concentration and eNOS, TAC, and smoking status in the whole group of patients. In the model estimated separately for smokers, the highest impact of eNOS (β = 0.375; p = 0.021) and cotinine (β = −0.323; p = 0.037) was indicated for NO concentration. In the model of non-smokers, eNOS (β = 0.291, p = 0.030) and TAC (β = 0.350; p = 0.015) were important for NO level. Smoking during pregnancy could exacerbate oxidative stress, impair the action of nitric oxide synthases, and adversely affect the balance of oxygen and nitrogen metabolism. Relationships between NO concentrations and TAC in the studied women’s blood can confirm the antioxidant nature of nitric oxide.

CEMTIRESTAT ATTENUATED NEUROLOGICAL DISORDERS IN RAT MODELS OF TYPE I AND TYPE II DIABETES: A BEHAVIORAL STUDY

2018 ◽  
Vol 25 (3) ◽  
pp. 217-218
Author(s):  
Marta Šoltésová Prnová ◽  
Karol Švík ◽  
Štefan Bezek ◽  
Lucia Kovaciková ◽  
Cimen Karasu ◽  
...  
Keyword(s):  
Neurological Disorders ◽  
Type Ii Diabetes ◽  
Type I ◽  
Behavioral Study ◽  
Type Ii ◽  
Rat Models

scholarly journals Efficacy of lanthionine-stabilized angiotensin-(1-7) in type I and type II diabetes mouse models

Peptides ◽  
2019 ◽  
Vol 112 ◽  
pp. 78-84 ◽  
Author(s):  
Anneke Kuipers ◽  
Gert N. Moll ◽  
Elizabeth Wagner ◽  
Rick Franklin
Keyword(s):  
Mouse Models ◽  
Type Ii Diabetes ◽  
Type I ◽  
Type Ii ◽  
Diabetes Mouse
Sign in / Sign up

Export Citation Format

Share Document